{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T02:24:28Z","timestamp":1786933468528,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21K15662"],"award-info":[{"award-number":["JP21K15662"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"DOI":"10.1007\/s12185-026-04268-1","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T01:45:47Z","timestamp":1786931147000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dimensionality reduction enables MRD visualization in single-sample flow cytometric analysis in acute leukemia"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2688-8522","authenticated-orcid":false,"given":"Shumpei","family":"Mizuta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahito","family":"Kawata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saya","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asami","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Ueshimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyuki","family":"Okuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Bandai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Hiranuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Tamekane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsumasa","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"issue":"7","key":"4268_CR1","doi-asserted-by":"publisher","first-page":"e170580","DOI":"10.1001\/jamaoncol.2017.0580","volume":"3","author":"DA Berry","year":"2017","unstructured":"Berry DA, Zhou S, Higley H, Mukundan L, Fu S, Reaman GH, et al. Association of minimal residual disease with clinical outcome in pediatric and adult acute lymphoblastic leukemia: a meta-analysis. JAMA Oncol. 2017;3(7):e170580. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0580.","journal-title":"JAMA Oncol"},{"issue":"12","key":"4268_CR2","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1001\/jamaoncol.2020.4600","volume":"6","author":"NJ Short","year":"2020","unstructured":"Short NJ, Zhou S, Fu C, Berry DA, Walter RB, Freeman SD, et al. Association of measurable residual disease with survival outcomes in patients with acute myeloid leukemia: a systematic review and meta-analysis. JAMA Oncol. 2020;6(12):1890\u20139. https:\/\/doi.org\/10.1001\/jamaoncol.2020.4600.","journal-title":"JAMA Oncol"},{"issue":"1","key":"4268_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1001\/jamaoncol.2016.3160","volume":"3","author":"NC Munshi","year":"2017","unstructured":"Munshi NC, Avet-Loiseau H, Rawstron AC, Owen RG, Child JA, Thakurta A, et al. Association of minimal residual disease with superior survival outcomes in patients with multiple myeloma: a meta-analysis. JAMA Oncol. 2017;3(1):28\u201335. https:\/\/doi.org\/10.1001\/jamaoncol.2016.3160.","journal-title":"JAMA Oncol"},{"key":"4268_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00689","volume":"9","author":"I Del Giudice","year":"2019","unstructured":"Del Giudice I, Raponi S, Della Starza I, De Propris MS, Cavalli M, De Novi LA, et al. Minimal residual disease in chronic lymphocytic leukemia: a new goal? Front Oncol. 2019;9:689. https:\/\/doi.org\/10.3389\/fonc.2019.00689.","journal-title":"Front Oncol"},{"issue":"1","key":"4268_CR5","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000676","volume":"6","author":"JM Tettero","year":"2021","unstructured":"Tettero JM, Freeman S, Buecklein V, Venditti A, Maurillo L, Kern W, et al. Technical aspects of flow cytometry-based measurable residual disease quantification in acute myeloid leukemia: experience of the European LeukemiaNet MRD Working Party. Hemasphere. 2021;6(1):e676. https:\/\/doi.org\/10.1097\/HS9.0000000000000676.","journal-title":"Hemasphere"},{"issue":"3","key":"4268_CR6","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1182\/blood-2016-07-726307","volume":"129","author":"P Theunissen","year":"2017","unstructured":"Theunissen P, Mejstrikova E, Sedek L, Van der Sluijs-Gelling AJ, Gaipa G, Bartels M, et al. Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia. Blood. 2017;129(3):347\u201357. https:\/\/doi.org\/10.1182\/blood-2016-07-726307.","journal-title":"Blood"},{"issue":"10","key":"4268_CR7","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1038\/leu.2017.29","volume":"31","author":"J Flores-Montero","year":"2017","unstructured":"Flores-Montero J, Sanoja-Flores L, Paiva B, Puig N, Garc\u00eda-S\u00e1nchez O, B\u00f6ttcher S, et al. Next generation flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma. Leukemia. 2017;31(10):2094\u2013103. https:\/\/doi.org\/10.1038\/leu.2017.29.","journal-title":"Leukemia"},{"issue":"4","key":"4268_CR8","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/leu.2015.313","volume":"30","author":"AC Rawstron","year":"2016","unstructured":"Rawstron AC, Fazi C, Agathangelidis A, Villamor N, Letestu R, Nomdedeu J, et al. A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study. Leukemia. 2016;30(4):929\u201336. https:\/\/doi.org\/10.1038\/leu.2015.313.","journal-title":"Leukemia"},{"issue":"Supplement 1","key":"4268_CR9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/ijlh.13548","volume":"43","author":"MC B\u00e9n\u00e9","year":"2021","unstructured":"B\u00e9n\u00e9 MC, Lacombe F, Porwit A. Unsupervised flow cytometry analysis in hematological malignancies: a new paradigm. Int J Lab Hematol. 2021;43(Supplement 1):54\u201364. https:\/\/doi.org\/10.1111\/ijlh.13548.","journal-title":"Int J Lab Hematol"},{"key":"4268_CR10","first-page":"2579","volume":"9","author":"L van der Maaten","year":"2009","unstructured":"van der Maaten L, Hinton G. Visualizing data using t-SNE. J Mach Learn Res. 2009;9:2579\u2013605.","journal-title":"J Mach Learn Res"},{"key":"4268_CR11","doi-asserted-by":"publisher","unstructured":"McInnes L, Healy J, Melville J. UMAP: uniform manifold approximation and projection for dimension reduction. arXiv preprint arXiv. 2018; 1802.03426. https:\/\/doi.org\/10.21105\/joss.00861","DOI":"10.21105\/joss.00861"},{"key":"4268_CR12","first-page":"1","volume":"22","author":"Y Wang","year":"2021","unstructured":"Wang Y, Huang H, Rudin C, Shaposhnik Y. Understanding how dimension reduction tools work: an empirical approach to deciphering t-SNE, UMAP, TriMAP and PaCMAP for data visualization. J Mach Learning Res. 2021;22:1\u201373.","journal-title":"J Mach Learning Res"},{"issue":"7","key":"4268_CR13","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/cyto.a.22625","volume":"87","author":"S Van Gassen","year":"2015","unstructured":"Van Gassen S, Callebaut B, Van Helden MJ, Lambrecht BN, Demeester P, Dhaene T, et al. FlowSOM: using self-organizing maps for visualization and interpretation of cytometry data. Cytometry A. 2015;87(7):636\u201345. https:\/\/doi.org\/10.1002\/cyto.a.22625.","journal-title":"Cytometry A"},{"issue":"1","key":"4268_CR14","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.cell.2015.05.047","volume":"162","author":"JH Levine","year":"2015","unstructured":"Levine JH, Simonds EF, Bendall SC, Davis KL, Amir e-AD, Tadmor MD, et al. Data-driven phenotypic dissection of AML reveals progenitor-like cells that correlate with prognosis. Cell. 2015;162(1):184\u201397. https:\/\/doi.org\/10.1016\/j.cell.2015.05.047.","journal-title":"Cell"},{"issue":"6","key":"4268_CR15","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nmeth.3863","volume":"13","author":"N Samusik","year":"2016","unstructured":"Samusik N, Good Z, Spitzer MH, Davis KL, Nolan GP. Automated mapping of phenotype space with single-cell data. Nat Methods. 2016;13(6):493\u20136. https:\/\/doi.org\/10.1038\/nmeth.3863.","journal-title":"Nat Methods"},{"issue":"4","key":"4268_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13040629","volume":"13","author":"JP Vial","year":"2021","unstructured":"Vial JP, Lechevalier N, Lacombe F, Dumas PY, Bidet A, Leguay T, et al. Unsupervised flow cytometry analysis allows for an accurate identification of minimal residual disease assessment in acute myeloid leukemia. Cancers (Basel). 2021;13(4):629. https:\/\/doi.org\/10.3390\/cancers13040629.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"4268_CR17","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/bjh.18802","volume":"202","author":"PC Nguyen","year":"2023","unstructured":"Nguyen PC, Nguyen V, Baldwin K, Kankanige Y, Blombery P, Came N, et al. Computational flow cytometry provides accurate assessment of measurable residual disease in chronic lymphocytic leukaemia. Br J Haematol. 2023;202(4):760\u201370. https:\/\/doi.org\/10.1111\/bjh.18802.","journal-title":"Br J Haematol"},{"issue":"3","key":"4268_CR18","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/cyto.b.21590","volume":"94","author":"E Alaterre","year":"2018","unstructured":"Alaterre E, Raimbault S, Garcia JM, R\u00e8me T, Requirand G, Klein B, et al. Automated and simplified identification of normal and abnormal plasma cells in multiple myeloma by flow cytometry. Cytometry B Clin Cytom. 2018;94(3):484\u201392. https:\/\/doi.org\/10.1002\/cyto.b.21590.","journal-title":"Cytometry B Clin Cytom"},{"issue":"4","key":"4268_CR19","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/cyto.b.22143","volume":"106","author":"MWC Verbeek","year":"2024","unstructured":"Verbeek MWC, Rodr\u00edguez BS, Sedek L, Laqua A, Buracchi C, Buysse M, et al. Minimal residual disease assessment in B-cell precursor acute lymphoblastic leukemia by semi-automated identification of normal hematopoietic cells: a EuroFlow study. Cytometry B Clin Cytom. 2024;106(4):252\u201363. https:\/\/doi.org\/10.1002\/cyto.b.22143.","journal-title":"Cytometry B Clin Cytom"},{"issue":"5","key":"4268_CR20","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/cyto.b.21252","volume":"88","author":"JA DiGiuseppe","year":"2015","unstructured":"DiGiuseppe JA, Tadmor MD, Pe\u2019er D. Detection of minimal residual disease in B lymphoblastic leukemia using viSNE. Cytometry B Clin Cytom. 2015;88(5):294\u2013304. https:\/\/doi.org\/10.1002\/cyto.b.21252.","journal-title":"Cytometry B Clin Cytom"},{"issue":"1","key":"4268_CR21","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1097\/MPH.0000000000003142","volume":"48","author":"K Kobayashi","year":"2026","unstructured":"Kobayashi K, Mizuta S, Ohashi Y, Yoshida S, Watanabe A, Takashima H, et al. Optimized flow cytometry incorporating t-SNE enables minimal residual disease assessment in a Philadelphia chromosome-positive acute lymphoblastic leukemia at or near the lower detection limit. J Pediatr Hematol Oncol. 2026;48(1):e21\u20135. https:\/\/doi.org\/10.1097\/MPH.0000000000003142.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"26","key":"4268_CR22","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1182\/blood.2021013626","volume":"138","author":"M Heuser","year":"2021","unstructured":"Heuser M, Freeman SD, Ossenkoppele GJ, Buccisano F, Hourigan CS, Ngai LL, et al. 2021 update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD working party. Blood. 2021;138(26):2753\u201367. https:\/\/doi.org\/10.1182\/blood.2021013626.","journal-title":"Blood"},{"issue":"4","key":"4268_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14040898","volume":"14","author":"L Weijler","year":"2022","unstructured":"Weijler L, Kowarsch F, W\u00f6dlinger M, Reiter M, Maurer-Granofszky M, Schumich A, et al. UMAP based anomaly detection for minimal residual disease quantification within acute myeloid leukemia. Cancers (Basel). 2022;14(4):898. https:\/\/doi.org\/10.3390\/cancers14040898.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"4268_CR24","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/cyto.b.22166","volume":"106","author":"DP Ng","year":"2024","unstructured":"Ng DP, Simonson PD, Tarnok A, Lucas F, Kern W, Rolf N, et al. Recommendations for using artificial intelligence in clinical flow cytometry. Cytometry B Clin Cytom. 2024;106(4):228\u201338. https:\/\/doi.org\/10.1002\/cyto.b.22166.","journal-title":"Cytometry B Clin Cytom"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04268-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-026-04268-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04268-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T01:45:48Z","timestamp":1786931148000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-026-04268-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":24,"alternative-id":["4268"],"URL":"https:\/\/doi.org\/10.1007\/s12185-026-04268-1","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"assertion":[{"value":"6 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}